Skip to main content

CANCER PROMOTION: understanding cancer promotion to inform prevention

3 Jun 24
- 5 Jun 24

The cancer research community is on the verge of a major leap in our understanding of the factors that contribute to human cancer risk. While it is clear that mutations in DNA, either spontaneous or environmentally induced, are essential for cancer development, recent advances have highlighted the importance of non-mutagenic factors as rate-limiting determinants of  cancer risk in human populations and in mouse cancer models. The root causes of human cancer have been widely debated, but most of the emphasis has been on the origins of the “driver” mutations that are ubiquitous in human tumours. Although epidemiology studies have highlighted the possible roles of lifestyle factors such as obesity, alcohol consumption and poor diet in cancer  risk, it has generally been assumed that these act directly or indirectly to cause mutations in  DNA, thus contributing to tumour mutational burden resulting in increased cancer risk. In contrast, recent sequencing studies have uncovered abundant mutations in normal human tissues,  suggesting that even strong cancer driver mutations are not sufficient for cancer formation. These results were presaged by studies of mouse tumour models, some carried out more than 70  years ago, showing that promotion is the rate-limiting step in tumour development.

The promoter hypothesis postulates that cells that acquire mutations through exposure to  exogenous or endogenous mutagenic factors accumulate cancer-driving mutations while maintaining normal tissue homeostasis. After exposure to a ‘promoting’ stimulus, such as chronic wounding, these ‘initiated’ cells, through an unknown mechanism, gain a selective advantage allowing them to undergo  clonal expansion and progress to malignancy.

This 41st edition of Biomed conference will provide an interdisciplinary forum for researchers interested in the principles of cancer promotion and in their implications for understanding tumor initiation and informed prevention. The conference will also showcase novel technologies to study clonal expansion in human normal tissues, promotion studies in organoids and model systems, and functional screens to reveal the mechanisms of promotion.

Topics

• Epidemiology, risk factors and cancer prevention

• Molecular mechanisms of cancer promotion

• Clonal expansions in normal tissues

• Modeling cancer promotion and prevention in organoids and model systems

Image

Presentation

Conference organizers

Image

Dr. Núria López-Bigas
IRB Barcelona/ICREA
Barcelona, Spain

Image
Dr. Allan Balmain

Dr. Allan Balmain
San Francisco,
CA, USA

Image
Dr. Paul Brennan

Dr. Paul Brennan
IARC
Lyon, France

 

There is no registration fee for this conference, but the number of participants is limited, with a number of seats saved for IRB Barcelona alumni. Previous registration is required.

Priority will be given to those who submit the highest quality abstracts for short talks or posters and the order of registration will be considered. 

Abstracts should include a title, authors, affiliations, summary (max 250 words) and references

Important dates

REGISTRATION DEADLINE: 15 APRIL, 2024

(Note: Any issue about the registration or abstract, please contact: meritxell.gavalda@irbbarcelona.org)

Venue

The BARCELONA BIOMED CONFERENCE CANCER PROMOTION: understanding cancer promotion to inform prevention will be placed at the Casa Convalescència in the heart of Barcelona. Talks will take place in the Aula Magna.

Casa Convalescència
C/ Sant Antoni Maria Claret, 171
08041 Barcelona

Tel +34 934 335 000
www.uab-casaconvalescencia.org

 

 

How to reach the Casa Convalescència:

Underground
Yellow line (L4) - GUINARDÓ – HOSPITAL DE SANT PAU station
Blue line (L5) - SANT PAU – DOS DE MAIG station

By bus
Lines: 15, 19, 20, 45, 47, 50, 51, 92 and 192.

For the GPS
Introduce the following coordinates:
Latitude: 41.413702 (41° 24' 49.33'' N)
Longitude: 2.177482 (2° 10' 38.94'' E)

From the airport

* Train + Underground. At the RENFE station, take the train to Sants-Estació. Once there take the Underground's blue line (L5) till SANT PAU – DOS DE MAIG station.
* Bus + Underground. Outside the airport terminal, take the AEROBUS to Plaça Catalunya. Walk one corner till Plaça Urquinaona and take the Underground's yellow line (L4) to GUINARDÓ – HOSPITAL DE SANT PAU station.

Barcelona Metropolitan Transport webiste (with metro and bus maps)

 

Accomodation

Speakers will be lodged at the Hotel Catalonia Sagrada Familia
Aragó 577- 579
08026, Barcelona
Telephone: +34 93 245 89 05

www.cataloniahotels.com/en/hotel/catalonia-sagrada-familia

Other hotels
A list of additional hotels within walking distance of the Casa Convalescència can be found at: https://www.barcelona-tourist-guide.com/en/hotels/hotelmaps/eixample-right-barcelona-hotel.html
(The Casa Convalescència is located near the violet point 27/3 star). Rates will vary depending on choice of hotel and season. Please check with the hotel of your choice directly for the best offer.

Residences
Another possibility is the Lesseps Residence Hall, and is available for short-term stays.

Lesseps Residence Hall
Plaza Lesseps, 12 08023 Barcelona
View on map
Telephone: +34 933 941 600
e-mail: lesseps@resa.es
www.resa.es/en/city/barcelona

Participants registered for events in the Barcelona BioMed series should contact the hotels and residences directly to arrange bookings and payment.

Speakers

Image
Dr. Direna Alonso-Curbelo

Dr. Direna Alonso-Curbelo
IRB Barcelona (Barcelona, Spain)

Image
Dr. Elsa Bernard

Dr. Elsa Bernard
Gustave Roussy (Villejuif, France)

Image
Dr. Kelly Bolton

Dr. Kelly Bolton
Washington University School of Medicine (St. Louis, MO, USA)

Image
Dr. George Davey-Smith

Dr. George Davey-Smith
Bristol University (Bristol, UK)

Image
Dr. James DeGregori

Dr. James DeGregori University of Colorado (Denver, CO, USA)

Image
Dr. Luke Gilbert

Dr. Luke Gilbert
Arc Institute (San Francisco, CA, USA)

Image
​​​​​​​Dr. Angela Goncalves

Dr. Angela Goncalves
DKFZ (Heidelberg, Germany)

Image
Dr. Douglas Hanahann

Dr. Douglas Hanahan
EPFL (Lausanne, Switzerland)

Image
Dr. Phil Jones

Dr. Phil Jones Wellcome Sanger Institute (Hinxton, UK)

Image
Dr. Calvin Kuo

Dr. Calvin Kuo
Stanford University School of Medicine (Stanford, CA, USA)

Image
Dr. Dan Landau

Dr. Dan Landau NY Genome Center (New York, NY, USA)

Image
Dr. Jyoti Nangalia

Dr. Jyoti Nangalia
Wellcome Sanger Institute (Hinxton, UK)

Image
Dr. Kamila Naxerova

Dr. Kamila Naxerova
Harvard University (CA, MA, USA)

Image
Dr. Richard Peto

Dr. Richard Peto
University of Oxford (Oxford, UK)

Image
Dr. Anya Plutynski

Dr. Anya Plutynski
Washington University (St. Louis, MO, USA)

Image
Dr. Raheleh Rahbari

Dr. Raheleh Rahbari
Wellcome Sanger Institute (Hinxton, UK)

Image
Dr. Rosana Risques

Dr. Rosana Risques
UW Medicine (Seattle, WA, USA)

Image
Dr. Alejo Rodriguez-Fraticelli

Dr. Alejo Rodriguez-Fraticelli
IRB Barcelona/ ICREA (Barcelona, Spain)

Image
Dr. Samra Turajlic

Dr. Samra Turajlic
The Francis Crick Institute (London, UK)

 

Registration

Gender
Title
Address
Where did you learn about this meeting
Are you interested in receiving notification about future IRB events?
Status
I will present
One file only.
64 MB limit.
Allowed types: txt, rtf, pdf, doc, docx, odt, ppt, pptx, odp, xls, xlsx, ods.